GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (FRA:RER1) » Definitions » Other Financing

Recordati SpA (FRA:RER1) Other Financing : €-16 Mil (TTM As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Recordati SpA Other Financing?

Recordati SpA's Other Financing for the three months ended in Sep. 2024 was €0 Mil.

Recordati SpA's Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 was €-16 Mil.

Recordati SpA Other Financing Historical Data

The historical data trend for Recordati SpA's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA Other Financing Chart

Recordati SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Recordati SpA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -16.23 - - -

Recordati SpA Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Recordati SpA Other Financing Related Terms

Thank you for viewing the detailed overview of Recordati SpA's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Recordati SpA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (FRA:RER1) » Definitions » Other Financing
Comparable Companies
MIL:CIRC MIL:SYS MIL:TNXT MIL:RETI MIL:NRST MIL:FOS MIL:AIW MIL:AGAIN MIL:SES MIL:ALK LLY OCSE:NOVO B JNJ ABBV MRK XSWX:ROG XSWX:NOVN LSE:AZN AMGN PFE
Traded in Other Exchanges
RICFY:USA REC:Italy RECm:UK 0KBS:UK RER1:Germany REC:Austria
Address
Via Matteo Civitali 1, MIlan, ITA, 20148
Website
https://www.recordati.com
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment which includes the production of active ingredients.

Recordati SpA Headlines

No Headlines